Effects of osteopontin on functional activity of late endothelial progenitor cells

Journal of Cellular Biochemistry

Volumn 112, Issue 7, 2011, Pages 1730-1736

  Yu, Min ^a   Liu, Qian ^a   Yi, Kaihong ^a   Wu, Libiao ^a   Tan, Xuerui ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Atherosclerosis; Late endothelial progenitor cells; Osteopontin

Indexed keywords

1,1' DIOCTADECYL 3,3,3',3' TETRAMETHYLINDOCARBOCYANINE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACETYL LOW DENSITY LIPOPROTEIN; OSTEOPONTIN; ULEX EUROPAEUS AGGLUTININ; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ARTICLE; CELL ADHESION; CELL FUNCTION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; DENSITY GRADIENT CENTRIFUGATION; ENDOTHELIAL PROGENITOR CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; LATE ENDOTHELIAL PROGENITOR CELL; MONONUCLEAR CELL; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD;

CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELL SHAPE; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FETAL BLOOD; HUMANS; INFANT, NEWBORN; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOPONTIN; STEM CELLS;

ULEX EUROPAEUS;

EID: 80051501202     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23071     Document Type: Article

References (30)

1. Asou Y, Rittling SR, Yoshitake H, Tsuji K, Shinomiya K, Nifuji A, Denhardt DT, Noda M. 2001. Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone. Endocrinology 142:1325-1332. . (Pubitemid 32202845)
2. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. 2001. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 107:1055-1061. . (Pubitemid 32422899)
3. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM. 1993. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 92:1686-1696. . (Pubitemid 23304531)
4. Grassinger J, Haylock DN, Storan MJ, Haines GO, Williams B, Whitty GA, Vinson AR, Be CL, Li S, Sørensen ES, Tam PP, Denhardt DT, Sheppard D, Choong PF, Nilsson SK. 2009. Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with alpha9beta1 and alpha4beta1 integrins. Blood 114:49-59. .
5. Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. 2005. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 45:1441-1448. . (Pubitemid 40615616)
6. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, Oh BH, Lee MM, Park YB. 2004. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24:288-293. . (Pubitemid 38197580)
7. Ikeda T, Shirasawa T, Esaki Y, Yoshiki S, Hirokawa K. 1993. Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J Clin Invest 92:2814-2820. . (Pubitemid 24006549)
8. Isoda K, Kamezawa Y, Ayaori M, Kusuhara M, Tada N, Ohsuzu F. 2003. Osteopontin transgenic mice fed a high-cholesterol diet develop early fattystreak lesions. Circulation 107:679-681. . (Pubitemid 36222592)
9. Isoda K, Nishikawa K, Kamezawa Y, Yoshida M, Kusuhara M, Moroi M, Tada N, Ohsuzu F. 2002. Osteopontin plays an important role in the development of medial thickening and neointimal formation. Circ Res 91:77-82. . (Pubitemid 34778945)
10. Iwakura A, Luedemann C, Shastry S, Hanley A, Kearney M, Aikawa R, Isner JM, Asahara T, Losordo DW. 2003. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 108:3115-3121. . (Pubitemid 38031801)
11. Katagiri YU, Sleeman J, Fujii H, Herrlich P, Hotta H, Tanaka K, Chikuma S, Yagita H, Okumura K, Murakami M, Saiki I, Chambers AF, Uede T. 1999. CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycineaspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res 59:219-226. . (Pubitemid 29062981)
12. Leali D, Moroni E, Bussolino F, Presta M. 2007. Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement. J Biol Chem 282:19676-19684. (Pubitemid 47100085)
13. Leen LL, Filipe C, Billon A, Garmy-Susini B, Jalvy S, Robbesyn F, Daret D, Allières C, Rittling SR, Werner N, Nickenig G, Deutsch U, Duplàa C, Dufourcq P, Lenfant F, Desgranges C, Arnal JF, Gadeau AP. 2008. Estrogen-stimulated endothelial repair requires osteopontin. Arterioscler Thromb Vasc Biol 28: 2131-2136. .
14. Liaw L, Lombardi DM, Almeida MM, Schwartz SM, deBlois D, Giachelli CM. 1997. Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation. Arterioscler Thromb Vasc Biol 17:188-193. . (Pubitemid 27057342)
15. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. 2000. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105: 71-77. (Pubitemid 30036389)
16. Lorenzen JM, Neunhöffer H, David S, Kielstein JT, Haller H, Fliser D. 2010. Angiotensin II receptor blocker and statins lower elevated levels of osteopontin in essential hypertension-results from the EUTOPIA trial. Atherosclerosis 209:184-188.
17. Matsui Y, Rittling SR, Okamoto H, Inobe M, Jia N, Shimizu T, Akino M, Sugawara T, Morimoto J, Kimura C, Kon S, Denhardt D, Kitabatake A, Uede T. 2003. Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 23:1029-1034. (Pubitemid 36713556)
18. Momiyama Y, Ohmori R, Fayad ZA, Kihara T, Tanaka N, Kato R, Taniguchi H, Nagata M, Nakamura H, Ohsuzu F. 2010. Associations between plasma osteopontin levels and the severities of coronary and aortic atherosclerosis. Atherosclerosis 210:668-670.
19. Murayama T, Tepper OM, Silver M, Ma H, Losordo DW, Isner JM, Asahara T, Kalka C. 2002. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization. Exp Hematol 30:967-972. (Pubitemid 34838899)
20. Nilsson SK, Johnston HM, Whitty GA, Williams B, Webb RJ, Denhardt DT, Bertoncello I, Bendall LJ, Simmons PJ, Haylock DN. 2005. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 106:1232-1239. (Pubitemid 41129584)
21. O'Brien ER, Garvin MR, Stewart DK, Hinohara T, Simpson JB, Schwartz SM, Giachelli CM. 1994. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb 14:1648-1656.
22. Ohmori R, Momiyama Y, Taniguchi H, Takahashi R, Kusuhara M, Nakamura H, Ohsuzu F. 2003. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis 170:333-337. (Pubitemid 37377807)
23. Reinholt FP, Hultenby K, Oldberg A, Heinegård D. 1990. Osteopontin-a possible anchor of osteoclasts to bone. Proc Natl Acad Sci USA 87:4473-4475.
24. Schmidt-Lucke C, Rössig L, Fichtlscherer S, Vasa M, Britten M, Kämper U, Dimmeler S, Zeiher AM. 2005. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111:2981-2987. (Pubitemid 40814192)
25. Shantsila E, Watson T, Lip GY. 2007. Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol 49:741-752.
26. Stier S, Ko Y, Forkert R, Lutz C, Neuhaus T, Grünewald E, Cheng T, Dombkowski D, Calvi LM, Rittling SR, Scadden DT. 2005. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exp Med 201:1781-1791. (Pubitemid 41002897)
27. Strehlow K, Werner N, Berweiler J, Link A, Dirnagl U, Priller J, Laufs K, Ghaeni L, Milosevic M, Bohm M, Nickenig G. 2003. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 107:3059-3065. (Pubitemid 36758980)
28. Suzuki T, Nishida M, Futami S, Fukino K, Amaki T, Aizawa K, Chiba S, Hirai H, Maekawa K, Nagai R. 2003. Neoendothelialization after peripheral blood stem cell transplantation in humans. A case report of a Tokaimura nuclear accident victim. Cardiovasc Res 58:487-492. (Pubitemid 36570407)
29. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G. 2005. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353:999-1007. (Pubitemid 41262334)
30. Yoon CH, Hur J, Park KW, Kim JH, Lee CS, Oh IY, Kim TY, Cho HJ, Kang HJ, Chae IH, Yang HK, Oh BH, Park YB, Kim HS. 2005. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 112:1618-1627. (Pubitemid 41324524)